0.25 mg to ml semaglutide Wegovy (semaglutide) Injector mg/0.5 (4-Pack) — Mountainside Medical Obesema(Semaglutide) 0.25mg Injection (1 Multi-dose

These symptoms range from mild to severe and can persist with continued use

It analyzes pathway-level variants (FTO (rs9939609), and MC4R (rs17782313)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction

Other neurological disorders The neuroprotective and anti-inflammatory properties of GLP-1RAs have prompted investigation into their therapeutic potential across a wide range of neurological conditions beyond AD and PD

December 2025: On December 15, 2025, the Judicial Panel on Multidistrict Litigation entered an order approving the creation of an MDL to house federal vision loss claims for Wegovy and other GLP-1 drugs

If you're on stimulant ADHD therapy, our prescribers may recommend a baseline EKG or additional monitoring, especially if you have any personal or family history of arrhythmias or hypertension